A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia
暂无分享,去创建一个
Connie Y. C. Ma | N. Daver | K. Yee | J. Brandwein | D. Pollyea | J. Jurcic | A. Salhotra | D. Samineni | S. Assouline | Randall C Dere | Tony Pourmohamad | N. Podoltsev | T. Sumiyoshi | A. Vaze | J. Cooper | Mengsong Li